Literature DB >> 21867956

Antiscience and ethical concerns associated with advocacy of Lyme disease.

Paul G Auwaerter1, Johan S Bakken, Raymond J Dattwyler, J Stephen Dumler, John J Halperin, Edward McSweegan, Robert B Nadelman, Susan O'Connell, Eugene D Shapiro, Sunil K Sood, Allen C Steere, Arthur Weinstein, Gary P Wormser.   

Abstract

Advocacy for Lyme disease has become an increasingly important part of an antiscience movement that denies both the viral cause of AIDS and the benefits of vaccines and that supports unproven (sometimes dangerous) alternative medical treatments. Some activists portray Lyme disease, a geographically limited tick-borne infection, as a disease that is insidious, ubiquitous, difficult to diagnose, and almost incurable; they also propose that the disease causes mainly non-specific symptoms that can be treated only with long-term antibiotics and other unorthodox and unvalidated treatments. Similar to other antiscience groups, these advocates have created a pseudoscientific and alternative selection of practitioners, research, and publications and have coordinated public protests, accused opponents of both corruption and conspiracy, and spurred legislative efforts to subvert evidence-based medicine and peer-reviewed science. The relations and actions of some activists, medical practitioners, and commercial bodies involved in Lyme disease advocacy pose a threat to public health.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21867956      PMCID: PMC4489928          DOI: 10.1016/S1473-3099(11)70034-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  34 in total

1.  Final report of the Lyme disease review panel of the Infectious Diseases Society of America.

Authors:  Paul M Lantos; William A Charini; Gerald Medoff; Manuel H Moro; David M Mushatt; Jeffrey Parsonnet; John W Sanders; Carol J Baker
Journal:  Clin Infect Dis       Date:  2010-07-01       Impact factor: 9.079

2.  Evidence-based guidelines for the management of Lyme disease.

Authors:  Daniel Cameron; Andrea Gaito; Nick Harris; Gregory Bach; Sabra Bellovin; Kenneth Bock; Steven Bock; Joseph Burrascano; Constance Dickey; Richard Horowitz; Steven Phillips; Laurence Meer-Scherrer; Bernard Raxlen; Virginia Sherr; Harold Smith; Pat Smith; Raphael Stricker
Journal:  Expert Rev Anti Infect Ther       Date:  2004       Impact factor: 5.091

Review 3.  A critical appraisal of "chronic Lyme disease".

Authors:  Henry M Feder; Barbara J B Johnson; Susan O'Connell; Eugene D Shapiro; Allen C Steere; Gary P Wormser; W A Agger; H Artsob; P Auwaerter; J S Dumler; J S Bakken; L K Bockenstedt; J Green; R J Dattwyler; J Munoz; R B Nadelman; I Schwartz; T Draper; E McSweegan; J J Halperin; M S Klempner; P J Krause; P Mead; M Morshed; R Porwancher; J D Radolf; R P Smith; S Sood; A Weinstein; S J Wong; L Zemel
Journal:  N Engl J Med       Date:  2007-10-04       Impact factor: 91.245

4.  A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated.

Authors:  S E Phillips; L H Mattman; D Hulínská; H Moayad
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

Review 5.  Antibiotic treatment of animals infected with Borrelia burgdorferi.

Authors:  Gary P Wormser; Ira Schwartz
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

6.  Evaluation of a new culture medium for Borrelia burgdorferi.

Authors:  A R Marques; F Stock; V Gill
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

7.  Role of psychiatric comorbidity in chronic Lyme disease.

Authors:  Afton L Hassett; Diane C Radvanski; Steven Buyske; Shantal V Savage; Michael Gara; Javier I Escobar; Leonard H Sigal
Journal:  Arthritis Rheum       Date:  2008-12-15

8.  Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study.

Authors:  J Oksi; J Nikoskelainen; H Hiekkanen; A Lauhio; M Peltomaa; A Pitkäranta; D Nyman; H Granlund; S-A Carlsson; I Seppälä; V Valtonen; M Viljanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

Review 9.  Bartonella spp. transmission by ticks not established.

Authors:  Sam R Telford; Gary P Wormser
Journal:  Emerg Infect Dis       Date:  2010-03       Impact factor: 6.883

10.  A broken trust: lessons from the vaccine--autism wars.

Authors:  Liza Gross
Journal:  PLoS Biol       Date:  2009-05-26       Impact factor: 8.029

View more
  25 in total

Review 1.  [Choosing wisely recommendations in rheumatology : One year after their first publication].

Authors:  E Märker-Hermann; A J Voormann
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

2.  [Lyme borreliosis].

Authors:  P Herzer; V Fingerle; H-W Pfister; A Krause
Journal:  Internist (Berl)       Date:  2014-07       Impact factor: 0.743

Review 3.  ["Choosing wisely" in infectious diseases : Overuse of antibiotics - too few vaccinations].

Authors:  N Jung; H Koop; R Riessen; J-C Galle; B Jany; E Märker-Hermann
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

4.  [Diagnosis and treatment of Lyme arthritis. Recommendations of the Pharmacotherapy Commission of the Deutsche Gesellschaft für Rheumatologie (German Society for Rheumatology)].

Authors:  M Gaubitz; F Dressler; H I Huppertz; A Krause
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

5.  Comparison of Tick Feeding Success and Vector Competence for Borrelia burgdorferi Among Immature Ixodes scapularis (Ixodida: Ixodidae) of Both Southern and Northern Clades.

Authors:  Jerome Goddard; Monica Embers; Andrias Hojgaard; Joseph Piesman
Journal:  J Med Entomol       Date:  2015-01       Impact factor: 2.278

6.  Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis.

Authors:  Rick Dersch; Antonia A Sarnes; Monika Maul; Tilman Hottenrott; Annette Baumgartner; Sebastian Rauer; Oliver Stich
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

7.  Live Attenuated Borrelia burgdorferi Targeted Mutants in an Infectious Strain Background Protect Mice from Challenge Infection.

Authors:  Beth L Hahn; Lavinia J Padmore; Laura C Ristow; Michael W Curtis; Jenifer Coburn
Journal:  Clin Vaccine Immunol       Date:  2016-08-05

8.  Electronic Support Groups: An Open Line of Communication in Contested Illness.

Authors:  Michael Murphy; Nicholas Kontos; Oliver Freudenreich
Journal:  Psychosomatics       Date:  2016-04-29       Impact factor: 2.386

9.  [Choosing wisely together with the patient].

Authors:  U R Fölsch; G Hasenfuß
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

Review 10.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.